Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramDirector, President and CEOCIK 0002005474
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Claypoole Robert EDirector, President and CEO |  BVSBioventus Inc.Option exercise | M | — 33.5K sh | Mar 17, 2026 traded Mar 13, 2026 | |
Claypoole Robert EDirector, President and CEO |
| BVSBioventus Inc. Grant or award |
| A |
| — 278.0K sh |
| Mar 17, 2026 traded Mar 13, 2026 |
| 9 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Grant or award | A | — 309.0K sh | Mar 17, 2026 traded Mar 13, 2026 |
| 21 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Option exercise | M | — 33.5K sh | Mar 17, 2026 traded Mar 13, 2026 |
| 16 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Tax withholding | F | $125K 14.6K sh | Mar 17, 2026 traded Mar 13, 2026 |
| 24 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Grant or award | A | — 134.0K sh | Mar 17, 2026 traded Mar 14, 2025 |
| 24 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Grant or award | A | — 153.0K sh | Mar 17, 2026 traded Mar 14, 2025 |
| 21 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Option exercise | M | — 93.8K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 21 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Option exercise | M | — 93.8K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 27 | Claypoole Robert EDirector, President and CEO | BVSBioventus Inc. Tax withholding | F | $335K 41.7K sh | Jan 13, 2026 traded Jan 9, 2026 |